Lip GYH - Search Results

1

Chronic Oral Anticoagulation Therapy and Prognosis of Patients Admitted to Hospital for COVID-19: Insights from the HOPE COVID-19 Registry.

Rivera-Caravaca JM, Núñez-Gil IJ, Lip GYH, Uribarri A, Viana-Llamas MC, Gonzalez A, Castro-Mejía AF, Alonso González B, Alfonso E, García Prieto JF, Cavallino C, Cortese B, Feltes G, Fernández-Rozas I, Signes-Costa J, Huang J, García Aguado M, Pepe M, Romero R, Cerrato E, Becerra-Muñoz VM, Raposeiras Roubin S, Santoro F, Bagur R, Sposato L, El-Battrawy I, López Masjuan A, Fernandez-Ortiz A, Estrada V, Macaya C, Marín F. Rivera-Caravaca JM, et al. Among authors: lip gyh. Int J Clin Pract. 2022 May 26;2022:7325060. doi: 10.1155/2022/7325060. eCollection 2022. Int J Clin Pract. 2022. PMID: 35685504 Free PMC article.

2

Fibrinolytic function and atrial fibrillation.

Marín F, Roldán V, Lip GY. Marín F, et al. Thromb Res. 2003 Mar 15;109(5-6):233-40. doi: 10.1016/s0049-3848(03)00259-7. Thromb Res. 2003. PMID: 12818244 Review.

3

Interleukin-6, endothelial activation and thrombogenesis in chronic atrial fibrillation.

Roldán V, Marín F, Blann AD, García A, Marco P, Sogorb F, Lip GY. Roldán V, et al. Eur Heart J. 2003 Jul;24(14):1373-80. doi: 10.1016/s0195-668x(03)00239-2. Eur Heart J. 2003. PMID: 12871695

4

Matrix metalloproteinases in atrial fibrillation.

Marín F, Roldán V, Climent V, Lip GY. Marín F, et al. J Am Coll Cardiol. 2004 Jan 7;43(1):152; author reply 152-3. doi: 10.1016/j.jacc.2003.10.019. J Am Coll Cardiol. 2004. PMID: 14715200 Free article. No abstract available.

5

A pharmacogenetic effect of factor XIII valine 34 leucine polymorphism on fibrinolytic therapy for acute myocardial infarction.

Marín F, González-Conejero R, Lee KW, Corral J, Roldán V, López F, Sogorb F, Caturla J, Lip GY, Vicente V. Marín F, et al. J Am Coll Cardiol. 2005 Jan 4;45(1):25-9. doi: 10.1016/j.jacc.2004.09.051. J Am Coll Cardiol. 2005. PMID: 15629368 Free article.

6

Relation of interleukin-6 levels and prothrombin fragment 1+2 to a point-based score for stroke risk in atrial fibrillation.

Roldán V, Marín F, Martínez JG, García-Herola A, Sogorb F, Lip GY. Roldán V, et al. Am J Cardiol. 2005 Apr 1;95(7):881-2. doi: 10.1016/j.amjcard.2004.12.016. Am J Cardiol. 2005. PMID: 15781023

7

Genetic polymorphisms and thromoembolic risk in atrial fibrillation.

Marín F, Roldán V, Tello A, Lip GY. Marín F, et al. J Thromb Thrombolysis. 2004 Oct;18(2):151-2. doi: 10.1007/s11239-004-0211-y. J Thromb Thrombolysis. 2004. PMID: 15789181 No abstract available.

8

Are there ethnic differences in the circadian variation in onset of acute myocardial infarction? A comparison of 3 ethnic groups in Birmingham, UK and Alicante, Spain.

López F, Lee KW, Marín F, Roldán V, Sogorb F, Caturla J, Lip GY. López F, et al. Int J Cardiol. 2005 Apr 8;100(1):151-4. doi: 10.1016/j.ijcard.2004.12.002. Int J Cardiol. 2005. PMID: 15820298

9

Correlation of plasma von Willebrand factor levels, an index of endothelial damage/dysfunction, with two point-based stroke risk stratification scores in atrial fibrillation.

Roldán V, Marín F, García-Herola A, Lip GY. Roldán V, et al. Thromb Res. 2005;116(4):321-5. doi: 10.1016/j.thromres.2005.01.005. Epub 2005 Feb 8. Thromb Res. 2005. PMID: 16038717

10

Is an advanced age an additive risk factor to the prothrombotic or hypercoagulable state in atrial fibrillation?

Roldán V, Marín F, García A, Tello-Montoliu A, Lip GY. Roldán V, et al. Int J Cardiol. 2006 Jun 16;110(2):265-6. doi: 10.1016/j.ijcard.2005.08.057. Epub 2005 Nov 28. Int J Cardiol. 2006. PMID: 16316692 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,643 results

Search Page

Filters